BIM
FLNA

Bogle Investment Management’s Filana Therapeutics FLNA Stock Holding History

Bogle Investment Management’s Portfolio FLNA Stock Details FLNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-2,681
Closed -$107K – 394
2014
Q2 		$107K Sell
2,681
-21,848
-89% -$808K 0.01% 325
2014
Q1 		$944K Buy
+24,529
New +$866K 0.06% 272

Other funds holding FLNA

First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
MSP
Madison Street Partners Denver, Colorado $3.05M AUM 5.94% 1-Year Est. Return
GPP
Great Point Partners Greenwich, Connecticut $435M AUM 318.81% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Bogle Investment Management's FLNA Position: Q3 2014 in Review

Bogle Investment Management sold out of Filana Therapeutics (FLNA) in Q3 2014, closing a stake of 2,681 shares — an estimated $107K sold.

Bogle Investment Management first reported a position in FLNA in Q1 2014 and held it in 2 quarters. The position peaked at $944K in Q1 2014. 73 funds tracked by Wall St. Rank hold FLNA as of Q3 2014.

  • Bogle Investment Management reported no remaining Filana Therapeutics position as of Q3 2014 after selling out during the quarter.
  • Bogle Investment Management sold 2,681 Filana Therapeutics shares in Q3 2014, an estimated $107K.
  • Bogle Investment Management first reported a position in Filana Therapeutics in Q1 2014 and held it in 2 quarters.
  • Bogle Investment Management's Filana Therapeutics position peaked at $944K in Q1 2014.
  • 73 funds tracked by Wall St. Rank held Filana Therapeutics as of Q3 2014.

Based on Bogle Investment Management's 13F filing for Q3 2014, filed 13 Nov 2014.